Century Therapeutics Statistics
NASDAQ: IPSCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.17-0.155 (-11.74%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Century Therapeutics by the numbers
Century Therapeutics has a market capitalization of $211.6 million based on 181.60M shares outstanding. With trailing EPS of $-0.64, Century Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.3% below its 50-day average and 43.3% below its 200-day average.
Average daily trading volume is 759.69K shares, or about $885,042 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IPSC valuation vs. peer median
| Metric | IPSC | Peer median | Difference |
|---|---|---|---|
| Market cap | $211.56M | $209.71M | +1% |
| Avg. volume | 759.69K | 1.27M | -40% |
Peer median across 8 companies: ALLO, CABA, LCTX, SCTX, ARTV, IKT, AUTL, PLX.
Valuation
- Market cap
- $211.56M
- Price / sales (latest FY)
- 1.94
- EPS (TTM)
- $-0.64
- Shares outstanding
- 181.60M
Price and trading
- Previous close
- 1.32
- Open
- 1.32
- Day range
- 1.16 – 1.32
- 52-week range
- 0.48 – 3.04
- 52-week change
- +137.76%
- Beta
- —
- Volume
- 916.11K
- Average volume
- 759.69K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 211.56M
- Forward Pe
- -2.68
- Eps
- -0.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.04
- Week52 Low
- 0.48
- Avg Volume
- 759.69K
- Shares Outstanding
- 181.60M
- Ma50
- 1.58
- Ma200
- 2.05
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -61.68%
- Pct From52w Low
- 142.71%